Manufacturing News

EMVision completes pilot line, receives $1.25 million grant payment

Manufacturing News

Brain imaging company EMVision Medical Devices has completed its pilot commercial line and received a third and final milestone-related payment, worth $1.25 million, under the federal Modern Manufacturing Initiative.

EMVision is developing bedside and portable machines for detecting stroke, with the former (known as emu) currently in clinical trials.

In a statement to the ASX on Monday, EMVision said the newly-completed pilot line for the first-generation product at Macquarie Park “has the initial capacity to build, test and release approximately one emu brain scanner per week”.

The company was awarded a $5 million grant under the Modern Manufacturing Initiative’s Manufacturing Translation Stream in October 2022. This came with a $2 million initial grant payment, and another $1.75 million payment in June last year.

EMVision was spun out of University of Queensland in 2017 to commercialise techniques using low-power microwaves to rapidly map brain tissue. 

The company’s devices are designed to detect if a stroke has occurred within minutes so treatment can be more rapidly decided on versus established methods.

Further reading

EMVision receives $1.75 million grant milestone payment

Government grants EMVision funding for brain scanner

EMVision moves to new trial phase of stroke detector

Medtech innovator explains the rush to save brains

Share this Story
Manufacturing News

Stay Informed

Go to Top